| Event chart NOVAVAX, INC. |
|
|
|
| Upcoming events on NOVAVAX, INC. |
|
| 06/16/22 | | Annual General Meeting |
| 08/10/22 | | Interim 2022 Earnings Release (Projected) |
| 11/09/22 | | Q3 2022 Earnings Release (Projected) |
| 02/27/23 | | FY 2022 Earnings Release (Projected) |
| 05/08/23 | | Q1 2023 Earnings Release (Projected) |
|
| Past events on NOVAVAX, INC. |
|
| 05/11/22 | 08:20pm | | Bank of America Healthcare Conference |
| 05/09/22 | 04:30pm | | Q1 2022 Earnings Call |
| 05/09/22 | 04:02pm | | Q1 2022 Earnings Release |
| 03/08/22 | 09:50am | | Cowen & Co. Health Care Conference |
| 02/28/22 | 04:30pm | | FY 2021 Earnings Call |
| 02/28/22 | 04:02pm | | FY 2021 Earnings Release |
| 02/16/22 | 11:20am | | SVB Leerink Global Healthcare Conference |
| 02/10/22 | 04:30pm | | NVX-CoV2373 Phase 3 Clinical Trial Results Call |
| 01/10/22 | 09:00am | | JP Morgan Healthcare Conference |
| 12/22/21 | 04:30pm | | Business Update Call |
|
| Past dividends on NOVAVAX, INC. |
|
- No events available -
|
|
|
| Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales
M $ |
Released
Forecast
Spread | 31,2
28,7
8,5% | 34,3
35,3
-2,8% | 18,7
11,8
58% | 476
398
19% | 1 146
1 263
-9,3% |
4 278
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -154
-149
-3,8% | -166
-158
-4,6% |
|
|
|
1 829
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -172
-168
-2,1% | -174
-172
-1,3% | -130
-121
-7,5% | -417
-393
-6,0% | -1 687
-979
-72% |
2 063
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -184
-180
-2,3% | -185
-182
-1,4% | -133
-128
-3,9% | -418
-383
-9,3% | -1 715
-1 007
-70% |
2 087
|
Net income
M $ |
Released
Forecast
Spread | -184
-180
-2,0% | -185
-182
-1,4% | -133
-130
-2,4% | -418
-383
-9,3% | -1 744
-1 021
-71% |
1 941
|
EPS
$ |
Released
Forecast
Spread | -12,6
-12,4
-1,5% | -10,0
-10,2
2,4% | -5,51
-5,42
-1,6% | -7,27
-6,58
-11% | -23,4
-13,7
-71% |
23,7
| | Announcement Date | 03/14/2018 | 03/18/2019 | 03/11/2020 | 03/01/2021 | 02/28/2022 | - |
|
|
|
| Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
Sales
M $ |
Released
Forecast
Spread | 3,38
1,93
75% | 35,5
39,6
-10% | 157
231
-32% | 280
202
38% | 447
234
91% | 298
388
-23% | 179
347
-49% | 222
332
-33% | 704
845
-17% |
997
|
1 142
|
1 412
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -22,9
-33,7
32% | -17,0
-16,8
-1,4% | -194
113
-272% | -183
-159
-15% | -209
-256
19% | -346
-269
-29% | -307
-275
-12% | -825
-114
-627% | 209
247
-15% |
469
|
573
|
795
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -25,9
-36,3
29% | -17,5
-17,7
0,99% | -197
88,1
-324% | -178
-142
-25% | -220
-265
17% | -349
-271
-29% | -316
-276
-15% | -830
-118
-605% | 206
242
-15% |
473
|
590
|
799
|
Net income
M $ |
Released
Forecast
Spread | -25,9
-36,9
30% | -17,5
-35,0
50% | -197
109
-280% | -178
-142
-25% | -223
-256
13% | -352
-271
-30% | -322
-282
-14% | -846
-124
-584% | 203
213
-4,7% |
436
|
540
|
746
|
EPS
$ |
Released
Forecast
Spread | -0,58
-0,71
19% | -0,30
-0,53
44% | -3,21
1,73
-285% | -2,70
-2,24
-21% | -3,05
-3,60
15% | -4,75
-3,25
-46% | -4,31
-3,73
-16% | -11,2
-1,80
-520% | 2,56
2,65
-3,5% |
5,33
|
6,57
|
9,00
| | Announcement Date | 05/11/2020 | 08/10/2020 | 11/09/2020 | 03/01/2021 | 05/10/2021 | 08/05/2021 | 11/04/2021 | 02/28/2022 | 05/09/2022 | - | - | - | |
|
|
| Upcoming sector events for NOVAVAX, INC. |
|
| |
|
| Past sector events for NOVAVAX, INC. |
|
| |
|
|
|
|
Australia says no to 16-year-old forklift drivers as remedy to COVID supply chain pain |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year
